» Articles » PMID: 36059829

Role of Leukocytes and Systemic Inflammation Indexes (NLR, PLR, MLP, DNLR, NLPR, AISI, SIR-I, and SII) on Admission Predicts In-hospital Mortality in Non-elderly and Elderly COVID-19 Patients

Overview
Specialty General Medicine
Date 2022 Sep 5
PMID 36059829
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Systemic inflammation indices, including neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), platelet/lymphocyte ratio (PLR), derived neutrophil/lymphocyte ratio (dNLR), neutrophil/lymphocyteplatelet ratio (NLPR), aggregate index of systemic inflammation (AISI), systemic inflammation response index (SIR-I), and systemic inflammation index (SII) are well-expressed inflammatory indices that have been used to predict the severity and mortality of various inflammatory diseases. This study aimed to investigate the role of systemic inflammatory markers in predicting mortality in non-elderly and elderly COVID-19 patients.

Methods: In a retrospective study, laboratory parameters were examined for 1,792 COVID-19 patients (elderly = 710 and non-elderly = 1,082). The ability of inflammatory markers to distinguish the severity of COVID-19 was determined by receiver operating characteristic (ROC) analysis, and survival probability was determined by the mean of Kaplan-Meier curves, with the endpoint being death.

Results: In the non-survivor non-elderly and elderly patients, the parameters PLR, MLR, dNLR, NLPR, AISI, SIR-I, and SII were significantly higher than in the surviving patients. WBC count (HR = 4.668, 95% CI = 1.624 to 13.413, < 0.01), neutrophil count (HR = 6.395, 95% CI = 2.070 to 19.760, < 0.01), dNLR (HR = 0.390, 95% CI = 0.182 to 0.835, < 0.05), and SII (HR = 10.725, 95% CI = 1.076 to 106.826, < 0.05) were significantly associated with survival. On the other hand, in elderly patients, it was found that WBC count (HR = 4.076, 95% CI = 2.176 to 7.637, < 0.001) and neutrophil count (HR = 2.412, 95% CI = 1.252 to 4.647, < 0.01) were significantly associated with survival.

Conclusion: WBC count and neutrophil count in non-elderly and elderly patients, were reliable predictors of mortality.

Citing Articles

Comparison of Platelet Indices, Lymphocyte, and Systemic Inflammation Indices on Days 1 and 8 in Surviving and Non-Surviving COVID-19 Patients at Hasan Sadikin General Hospital, Bandung, Indonesia.

Harti G, Maulida S, Susandi E, Fadjari T, Sumardi U, Alisjahbana B J Blood Med. 2025; 16:61-74.

PMID: 39926111 PMC: 11806915. DOI: 10.2147/JBM.S499023.


Bronchiolitis Severity Affects Blood Count and Inflammatory Marker Levels: A Real-Life Experience.

Gambadauro A, Mollica S, Rosa E, Xerra F, Li Pomi A, Valenzise M Viruses. 2025; 17(1).

PMID: 39861866 PMC: 11769181. DOI: 10.3390/v17010077.


Association of relative fat mass with asthma: inflammatory markers as potential mediators.

Zhou M, Zhang T, Zeng Z, Zeng S, Wang S, Wang H Lipids Health Dis. 2025; 24(1):13.

PMID: 39810140 PMC: 11731360. DOI: 10.1186/s12944-024-02428-y.


Neutrophil-to-Lymphocyte and Platelet Ratio (N/LP Ratio), a Reliable Criterion for Predicting In-Hospital Mortality in Both Genders Infected With SARS-CoV-2.

Mohammadshahi J, Ghobadi H, Shargi A, Moradkhani H, Rezaei H, Kazemy M Mediators Inflamm. 2025; 2024:5720709.

PMID: 39759900 PMC: 11699982. DOI: 10.1155/mi/5720709.


The Model for End-Stage Liver Disease (MELD) Score Predicting Mortality Due to SARS-CoV-2 in Mexican Patients.

Reyes-Ruiz J, Avelino-Santiago A, Martinez-Mier G, Lopez-Lopez C, De Jesus-Gonzalez L, Leon-Juarez M J Clin Med. 2024; 13(19).

PMID: 39407839 PMC: 11477146. DOI: 10.3390/jcm13195777.


References
1.
Medetalibeyoglu A, Senkal N, Kose M, Catma Y, Bilge Caparali E, Erelel M . Older Adults Hospitalized with Covid-19: Clinical Characteristics and Early Outcomes from a Single Center in Istanbul, Turkey. J Nutr Health Aging. 2020; 24(9):928-937. PMC: 7597420. DOI: 10.1007/s12603-020-1477-2. View

2.
Emily L, Gilad G, Haim M, Galina G . Functional dependency and COVID-19 in elderly patients with mild to moderate disease. Experience of tertiary geriatric hospital. Exp Gerontol. 2021; 157:111620. PMC: 8564951. DOI: 10.1016/j.exger.2021.111620. View

3.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

4.
Giammaria D, Pajewski A . Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?. J Glob Health. 2020; 10(1):010377. PMC: 7307801. DOI: 10.7189/jogh.10.010377. View

5.
Mori H, Obinata H, Murakami W, Tatsuya K, Sasaki H, Miyake Y . Comparison of COVID-19 disease between young and elderly patients: Hidden viral shedding of COVID-19. J Infect Chemother. 2020; 27(1):70-75. PMC: 7474868. DOI: 10.1016/j.jiac.2020.09.003. View